Journal of dental sciences · 2026
Cancer-associated fibroblast-derived interleukin-6 as a key driver of epithelial-mesenchymal transition and metastasis in oral squamous cell carcinoma.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Heo Soon Chul, Ryu Jihye, Keum Bo Ram, Bae Moon-Kyoung, Lee Jae-Yeol, Kim Hyung Joon
Аннотация
BACKGROUND/PURPOSE: Oral squamous cell carcinoma (OSCC) is a highly metastatic cancer with a poor prognosis, partly driven by epithelial-mesenchymal transition (EMT). Although several cytokines have been implicated in OSCC progression, the specific role of cancer-associated fibroblast (CAF)-derived interleukin-6 (IL-6) in EMT and metastasis remains poorly understood. This study investigated the contribution of CAF-derived IL-6 to the promotion of EMT and metastasis in OSCC.
MATERIALS AND METHODS: Conditioned media from gingival fibroblasts (GF) treated with OSCC-conditioned media (SCC25-GF CM) were analyzed using secretomic and functional assays. EMT marker expression, migration, and invasion were evaluated by RT-qPCR, Western blotting, immunofluorescence, and an IL-6 neutralizing antibody.
RESULTS: SCC25-GF CM significantly downregulated E-cadherin and upregulated N-cadherin, vimentin, and Snail expression, indicating EMT induction. Secretome analysis revealed elevated levels of multiple EMT- and metastasis-associated factors, including stromelysin-1, glia-derived nexin, tenascin, procathepsin L, and IL-6, in SCC25-GF CM. IL-6 neutralization reduced EMT marker expression, migration, and invasion in SCC25 cells, demonstrating that IL-6 is a key driver of CAF-mediated EMT in OSCC.
CONCLUSION: These findings indicate that IL-6 is a central mediator of CAF-induced EMT and contributes to the metastatic potential of OSCC, highlighting IL-6 as a promising therapeutic target.
MATERIALS AND METHODS: Conditioned media from gingival fibroblasts (GF) treated with OSCC-conditioned media (SCC25-GF CM) were analyzed using secretomic and functional assays. EMT marker expression, migration, and invasion were evaluated by RT-qPCR, Western blotting, immunofluorescence, and an IL-6 neutralizing antibody.
RESULTS: SCC25-GF CM significantly downregulated E-cadherin and upregulated N-cadherin, vimentin, and Snail expression, indicating EMT induction. Secretome analysis revealed elevated levels of multiple EMT- and metastasis-associated factors, including stromelysin-1, glia-derived nexin, tenascin, procathepsin L, and IL-6, in SCC25-GF CM. IL-6 neutralization reduced EMT marker expression, migration, and invasion in SCC25 cells, demonstrating that IL-6 is a key driver of CAF-mediated EMT in OSCC.
CONCLUSION: These findings indicate that IL-6 is a central mediator of CAF-induced EMT and contributes to the metastatic potential of OSCC, highlighting IL-6 as a promising therapeutic target.